GL, EJ, and CG were the principal investigators of the ELAM02, CBF-2006, and ALFA-1200 trials, respectively. NB, SDB, EL, CR, MS, PS, EJ, MB, GL, and AP enrolled patients in the different studies. HL created and handled the patient database. CT, IL and WC reviewed cytogenetic data. LF, ND, AM-R, and PC-L performed genomic analyses. LV and LF assembled and analyzed the data, and drafted the manuscript. JL supervised statistical analyses. LF, NB, and CP supervised the study. All authors revised the manuscript and accepted its final version.
Trending
- 40 An AI Digital Twin Compares Favorably to Radiologists for Landmark Identification and Measurement in Early-Stage Breast Cancer: A Retrospective, Multi-Institution Clinical Study
- 39 Predictors of Delay in Time From Diagnostic Breast Imaging to Needle Core Biopsy
- Postoperative dynamics of inflammatory markers in patients with uncomplicated recovery after colorectal cancer surgery: a preliminary inflammatory benchmarks study
- Kate completes Three Peaks challenge to raise money for cancer charity | Catherine, Princess of Wales
- Pirtobrutinib Earns Positive CHMP Opinion Across All CLL Treatment Lines
- What adolescents and young adults with cancer want researchers to know
- Ovarian cancer tumor immune profiles associated with intrauterine device and oral contraceptive use
- New vitamin B12 therapy shows promise against deadly brain cancer

